Taysha Gene Therapies, Inc. (TSHA)
4.005
-0.06
(-1.35%)
USD |
NASDAQ |
Nov 17, 16:00
4.005
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Price : 4.005 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 4.04 | 4.18 | 3.97 | 4.06 | 3.384M |
| Nov 13, 2026 | 4.24 | 4.330 | 3.975 | 4.10 | 2.475M |
| Nov 12, 2026 | 4.23 | 4.425 | 4.04 | 4.21 | 3.881M |
| Nov 11, 2026 | 4.32 | 4.32 | 4.185 | 4.28 | 2.116M |
| Nov 10, 2026 | 4.30 | 4.42 | 4.16 | 4.275 | 2.083M |
| Nov 09, 2026 | 4.41 | 4.53 | 4.25 | 4.37 | 3.357M |
| Nov 06, 2026 | 4.16 | 4.45 | 4.139 | 4.33 | 3.183M |
| Nov 05, 2026 | 4.38 | 4.40 | 4.00 | 4.09 | 6.743M |
| Nov 04, 2026 | 4.08 | 4.38 | 4.005 | 4.36 | 4.034M |
| Nov 03, 2026 | 4.05 | 4.165 | 3.92 | 4.09 | 1.729M |
| Nov 02, 2026 | 4.30 | 4.30 | 3.95 | 4.00 | 2.008M |
| Oct 30, 2026 | 4.18 | 4.25 | 4.07 | 4.13 | 1.501M |
| Oct 29, 2026 | 4.225 | 4.47 | 4.14 | 4.22 | 2.058M |
| Oct 28, 2026 | 4.24 | 4.28 | 4.12 | 4.23 | 3.403M |
| Oct 27, 2026 | 4.03 | 4.28 | 3.97 | 4.25 | 2.825M |
| Oct 26, 2026 | 3.98 | 4.09 | 3.95 | 4.01 | 1.820M |
| Oct 23, 2026 | 3.95 | 3.98 | 3.755 | 3.96 | 2.593M |
| Oct 22, 2026 | 4.07 | 4.175 | 3.935 | 4.005 | 3.105M |
| Oct 21, 2026 | 4.15 | 4.265 | 4.05 | 4.12 | 3.511M |
| Oct 20, 2026 | 3.95 | 4.20 | 3.89 | 4.11 | 10.93M |
| Oct 19, 2026 | 3.66 | 3.965 | 3.65 | 3.94 | 5.817M |
| Oct 16, 2026 | 3.73 | 3.745 | 3.60 | 3.62 | 2.752M |
| Oct 15, 2026 | 3.53 | 3.79 | 3.50 | 3.73 | 4.686M |
| Oct 14, 2026 | 3.51 | 3.715 | 3.455 | 3.51 | 4.343M |
| Oct 13, 2026 | 4.09 | 4.13 | 3.55 | 3.58 | 6.117M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Imunon, Inc. | 0.6166 |
| Altimmune, Inc. | 1.535 |
| Agenus, Inc. | 6.225 |
| Amgen, Inc. | 457.91 |
| Anika Therapeutics, Inc. | 12.89 |
Price Related Metrics
| PS Ratio | 260.46 |
| PEG Ratio | -0.3978 |
| Price to Book Value | 3.656 |
| Earnings Yield | -10.89% |
| Market Cap | 1.305B |
| PEGY Ratio | -0.3978 |